17 min

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19 Coronavirus (COVID-19) Q&A

    • Medicine

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

17 min

More by JAMA Network

JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Network
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Neurology Author Interviews
JAMA Network